18F-labelled gentiobiose as potential PET-radiotracer for specific bacterial imaging: precursor synthesis, radiolabelling and in vitro evaluation.

Nuklearmedizin. Nuclear medicine Pub Date : 2024-10-01 Epub Date: 2024-07-31 DOI:10.1055/a-2365-8054
Felicitas Landau, Sven Hermann, Sonja Schelhaas, Michael Schäfers, Silke Niemann, Andreas Faust
{"title":"18F-labelled gentiobiose as potential PET-radiotracer for specific bacterial imaging: precursor synthesis, radiolabelling and in vitro evaluation.","authors":"Felicitas Landau, Sven Hermann, Sonja Schelhaas, Michael Schäfers, Silke Niemann, Andreas Faust","doi":"10.1055/a-2365-8054","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>Bacterial infections are a clinical challenge, requiring fast and specific diagnosis to ensure effective treatment. Therefore, this project is dedicated to development of positron emission tomography (PET) radiotracers specifically targeting bacteria. Unlike previously developed bacteria-specific radiotracers, which are successful in detecting Gram-negative bacteria, tracers capable of imaging Gram-positive infections are still lacking.</p><p><strong>Methods: </strong>The disaccharide gentiobiose as abundant part of the cell wall of Gram-positive bacteria could fill this gap. Herein, the synthesis and evaluation of 2'-deoxy-2'-[<sup>18</sup>F]fluorogentiobiose ([<sup>18</sup>F]FLA280) is reported. The precursor for radiolabelling was obtained from a convergent synthesis under application of a benzylidene/benzyl group protecting strategy.</p><p><strong>Results: </strong>The first catalytic hydrogenation in <sup>18</sup>F-radiochemistry is reported as proof of concept. The deprotection was carried out without any side product formation, giving the final radiotracer [<sup>18</sup>F]FLA280 in good radiochemical yield and excellent radiochemical purity. [<sup>18</sup>F]FLA280 was proven to be stable in murine and human blood serum for 120 minutes and was subjected to <i>in vitro</i> bacterial uptake studies towards <i>S. aureus</i> and <i>E. coli</i> resulting in a low bacterial uptake.</p><p><strong>Conclusion: </strong>The observed bacterial uptake indicates that [<sup>18</sup>F]FLA280 may be not a promising tracer candidate for <i>in vivo</i> translation and alternative candidates particularly for Gram-positive bacteria are required. However, further development on the concept of labelled carbohydrates and cell wall building blocks might be promising.</p>","PeriodicalId":94161,"journal":{"name":"Nuklearmedizin. Nuclear medicine","volume":" ","pages":"300-305"},"PeriodicalIF":0.0000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nuklearmedizin. Nuclear medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/a-2365-8054","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/31 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: Bacterial infections are a clinical challenge, requiring fast and specific diagnosis to ensure effective treatment. Therefore, this project is dedicated to development of positron emission tomography (PET) radiotracers specifically targeting bacteria. Unlike previously developed bacteria-specific radiotracers, which are successful in detecting Gram-negative bacteria, tracers capable of imaging Gram-positive infections are still lacking.

Methods: The disaccharide gentiobiose as abundant part of the cell wall of Gram-positive bacteria could fill this gap. Herein, the synthesis and evaluation of 2'-deoxy-2'-[18F]fluorogentiobiose ([18F]FLA280) is reported. The precursor for radiolabelling was obtained from a convergent synthesis under application of a benzylidene/benzyl group protecting strategy.

Results: The first catalytic hydrogenation in 18F-radiochemistry is reported as proof of concept. The deprotection was carried out without any side product formation, giving the final radiotracer [18F]FLA280 in good radiochemical yield and excellent radiochemical purity. [18F]FLA280 was proven to be stable in murine and human blood serum for 120 minutes and was subjected to in vitro bacterial uptake studies towards S. aureus and E. coli resulting in a low bacterial uptake.

Conclusion: The observed bacterial uptake indicates that [18F]FLA280 may be not a promising tracer candidate for in vivo translation and alternative candidates particularly for Gram-positive bacteria are required. However, further development on the concept of labelled carbohydrates and cell wall building blocks might be promising.

18F 标记的龙胆二糖作为用于特异性细菌成像的潜在 PET 放射性示踪剂:前体合成、放射性标记和体外评估。
目的:细菌感染是一项临床挑战,需要快速和特异性诊断,以确保有效治疗。因此,本项目致力于开发专门针对细菌的正电子发射断层扫描(PET)放射性racers。与之前开发的成功检测革兰氏阴性细菌的细菌特异性放射性示踪剂不同,目前仍缺乏能对革兰氏阳性感染成像的示踪剂:方法:在革兰氏阳性细菌细胞壁中含量丰富的龙胆二糖可以填补这一空白。本文报告了 2'-deoxy-2'-[18F]fluorogentiobiose ([18F]FLA280) 的合成和评估。用于放射性标记的前体是在亚苄基/苄基保护策略下通过聚合合成获得的:结果:作为概念验证,首次报道了 18F 放射化学中的催化氢化反应。结果:作为概念验证,首次报道了 18F 放射化学中的催化氢化反应,去保护过程中没有形成任何副产物,最终得到的放射示踪剂 [18F]FLA280 具有良好的放射化学收率和极高的放射化学纯度。事实证明,[18F]FLA280 在小鼠和人类血清中 120 分钟内都很稳定,并对金黄色葡萄球菌和大肠杆菌进行了体外细菌摄取研究,结果显示细菌摄取量很低:结论:观察到的细菌摄取情况表明,[18F]FLA280 可能不是一种有希望用于体内转化的示踪剂候选物,需要其他候选物,特别是革兰氏阳性细菌。不过,进一步发展标记碳水化合物和细胞壁构筑物的概念可能很有希望。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信